p62蛋白在食管鳞癌细胞中核浆易位的机制研究

doi:10.3969/j.issn.1004-616x.2021.05.004

癌变·畸变·突变 ›› 2021, Vol. 33 ›› Issue (5): 338-344.doi: 10.3969/j.issn.1004-616x.2021.05.004

p62蛋白在食管鳞癌细胞中核浆易位的机制研究

杨荔艳¹, 刘奏², 郝佳洁², 张钰², 王明荣²

1. 国家癌症中心/国家肿瘤临床医学研究中心/中国医学科学院北京协和医学院肿瘤医院检验科, 北京 100021;
2. 国家癌症中心/国家肿瘤临床医学研究中心/中国医学科学院北京协和医学院肿瘤医院, 分子肿瘤学国家重点实验室, 北京 100021

收稿日期:2021-07-19 修回日期:2021-08-19 出版日期:2021-09-30 发布日期:2021-10-09
通讯作者: 王明荣,E-mail:wangmr2015@126.com;张钰,E-mail:zhangyu909@126.com E-mail:wangmr2015@126.com;zhangyu909@126.com
作者简介:杨荔艳,E-mail:yangliyan0729@163.com。
基金资助:
国家自然科学基金（81930077）

Study on the mechanism of nucleo-plasma translocation of p62 protein in esophageal squamous cell carcinoma

YANG Liyan¹, LIU Zou², HAO Jiajie², ZHANG Yu², WANG Mingrong²

1. Department of Clinical Laboratory, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021;
2. State Key Laboratory of Molecular Oncology, Center for Cancer Precision Medicine, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China

Received:2021-07-19 Revised:2021-08-19 Online:2021-09-30 Published:2021-10-09

摘要/Abstract

摘要： 目的：探讨p62蛋白在食管鳞癌细胞中核浆易位的影响因素及其可能机制。方法：采用核输出抑制剂KPT330处理食管鳞癌细胞KYSE70、KYSE150和KYSE510后，利用免疫荧光技术结合激光共聚焦显微镜分别观察抑制剂处理前后食管鳞癌细胞中p62蛋白的定位情况。利用液相色谱串联质谱（LC-MS/MS）磷酸化蛋白质组技术鉴定食管鳞癌细胞中p62蛋白的磷酸化位点。定点突变技术用于构建p62不同磷酸化状态的突变体。通过免疫共沉淀实验（Co-IP）、邻位连接实验（PLA）分析p62与GSK-3β的相互作用情况。结果：使用核输出抑制处理后，免疫荧光结合激光共聚焦显微镜观察发现，p62积聚在细胞核中。质谱鉴定结果显示，食管鳞癌细胞中p62蛋白存在T269/S272/S328/S332这4个位点的磷酸化，进一步发现T269/S272位点磷酸化、且同时S328/S332去磷酸化可使胞浆中的p62转移至细胞核中。Co-IP和PLA实验结果显示，p62与GSK-3β存在直接的相互作用。结论：食管鳞癌细胞中p62的核浆易位与其S328/S332磷酸化状态相关，且可能受GSK-3β激酶调控。

关键词: p62蛋白, 食管鳞癌, 核浆易位, 磷酸化, 糖原合成酶激酶3β

Abstract: OBJECTIVE: To explore possible mechanisms that mediated the translocation of p62 protein from nuclei into cytoplasm in esophageal squamous cell carcinoma. METHODS: After treatments with KPT330 in KYSE70,KYSE150 and KYSE510 ESCC cell lines,localizations of p62 were observed by immunofluorescence assay combined with confocal laser microscopy as compared with the untreated group. LC-MS/MS mass spectrometry was used to identify the phosphorylation sites of p62 in esophageal cancer cells. Site-directed mutagenesis was performed to construct mutants with different phosphorylation status of p62. Co-IP and PLA experiments were conducted to analyze interactions between p62 and GSK3β. p62 accumulated in the nucleus after treatment with nuclear export inhibitor. RESULTS: The results of mass spectrometry showed phosphorylation of p62 protein at four sites of T269/S272/S328/S332 in esophageal cancer cells. By transfecting different phosphorylated mutants of p62 into KYSE30 cells and KYSE150 cells with endogenous knockdown of p62,phosphorylation at T269/S272 and dephosphorylation of S328/S332 contributed to the transfer of p62 from cytoplasm to nucleus. Co-IP and PLA results showed direct interactions between p62 and GSK-3β. CONCLUSION: Our results indicates that nucleo-plasmic translocation of p62 in esophageal cancer cells was related to the phosphorylation status of S328/S332 and might be regulated by GSK-3β kinase.

Key words: p62 protein, esophageal squamous cell carcinoma, nucleo-plasma translocation, phosphorylation, GSK-3β

中图分类号:

R73.02

杨荔艳, 刘奏, 郝佳洁, 张钰, 王明荣. p62蛋白在食管鳞癌细胞中核浆易位的机制研究[J]. 癌变·畸变·突变, 2021, 33(5): 338-344.

YANG Liyan, LIU Zou, HAO Jiajie, ZHANG Yu, WANG Mingrong. Study on the mechanism of nucleo-plasma translocation of p62 protein in esophageal squamous cell carcinoma[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(5): 338-344.

参考文献

[1] CHEN W, ZHENG R, BAADE P D, et al. Cancer statistics in China, 2015[J]. CA:Cancer J Clin, 2016, 66(2):115-132.
[2] LAGERGREN J, SMYTH E, CUNNINGHAM D, et al. Oesophageal cancer[J]. Lancet, 2017, 390(10110):2383-2396.
[3] PENNATHUR A, GIBSON M K, JOBE B A, et al. Oesophageal carcinoma[J]. Lancet, 2013, 381(9864):400-412.
[4] SHI C, PAN B Q, SHI F, et al. Sequestosome 1 protects esophageal squamous carcinoma cells from apoptosis via stabilizing SKP2 under serum starvation condition[J]. Oncogene, 2018, 37(24):3260-3274.
[5] SÁNCHEZ-MARTÍN P, SAITO T, KOMATSU M. p62/SQSTM1:'Jack of all trades'in health and cancer[J]. Febs J, 2019, 286(1):8-23.
[6] LI D, HE C, YE F, et al. p62 overexpression promotes bone metastasis of lung adenocarcinoma out of LC3-dependent autophagy[J]. Front Oncol, 2021, 11:609548.
[7] YOKOTA A, HIRAMOTO M, HINO H, et al. Sequestosome 1(p62) accumulation in breast cancer cells suppresses progesterone receptor expression via argonaute 2[J]. Biochem Biophys Res Commun, 2020, 531(2):256-263.
[8] MAO Y, DENG S J, SU Y J, et al. The role of P62 in the development of human thyroid cancer and its possible mechanism[J]. Cancer Genet, 2021, 256/257:5-16.
[9] LEI C, ZHAO B, LIU L, et al. Expression and clinical significance of p62 protein in colon cancer[J]. Medicine:Baltimore, 2020, 99(3):e18791.
[10] BURDELSKI C, REISWICH V, HUBE-MAGG C, et al. Cytoplasmic accumulation of sequestosome 1(p62) is a predictor of biochemical recurrence, rapid tumor cell proliferation, and genomic instability in prostate cancer[J]. Clin Cancer Res, 2015, 21(15):3471-3479.
[11] PANKIV S, LAMARK T, BRUUN J A, et al. Nucleocytoplasmic shuttling of p62/SQSTM1 and its role in recruitment of nuclear polyubiquitinated proteins to promyelocytic leukemia bodies[J]. J Biol Chem, 2010, 285(8):5941-5953.
[12] ISLAM M, SOORO M, ZHANG P H. Autophagic regulation of p62 is critical for cancer therapy[J]. Int J Mol Sci, 2018, 19(5):1405.
[13] WANG S B, VENKATRAMAN V, CROWGEY E L, et al. Protein S-nitrosylation controls glycogen synthase kinase 3β function independent of its phosphorylation state[J]. Circ Res, 2018, 122(11):1517-1531.
[14] FRAME S, COHEN P. GSK₃ takes centre stage more than 20 years after its discovery[J]. Biochem J, 2001, 359(pt 1):1-16.
[15] JOPE R S. Lithium and GSK-3:one inhibitor, two inhibitory actions, multiple outcomes[J]. Trends Pharmacol Sci, 2003, 24(9):441-443.
[16] JOPE R S, JOHNSON G V. The glamour and gloom of glycogen synthase kinase-3[J]. Trends Biochem Sci, 2004, 29(2):95-102.
[17] LIN J T, SONG T, LI C, et al. GSK-3β in DNA repair, apoptosis, and resistance of chemotherapy, radiotherapy of cancer[J]. Biochim et Biophys Acta BBA Mol Cell Res, 2020, 1867(5):118659.
[18] GUO L, CHEN D K, YIN X, et al. GSK-3β promotes cell migration and inhibits autophagy by mediating the AMPK pathway in breast cancer[J]. Oncol Res, 2019, 27(4):487-494.
[19] CHEN R, ZHANG Y Y, LAN J N, et al. Ischemic postconditioning alleviates intestinal ischemia-reperfusion injury by enhancing autophagy and suppressing oxidative stress through the Akt/GSK-3β/Nrf2 pathway in mice[J]. Oxid Med Cell Longev, 2020, 2020:6954764.
[20] REN J L, LIU T T, HAN Y, et al. GSK-3β inhibits autophagy and enhances radiosensitivity in non-small cell lung cancer[J]. Diagn Pathol, 2018, 13(1):1-10.
[21] WEIBRECHT I, LEUCHOWIUS K J, CLAUSSON C M, et al. Proximity ligation assays:a recent addition to the proteomics toolbox[J]. Expert Rev Proteom, 2010, 7(3):401-409.

p62蛋白在食管鳞癌细胞中核浆易位的机制研究

Study on the mechanism of nucleo-plasma translocation of p62 protein in esophageal squamous cell carcinoma

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	杨兴肖, 张雪原, 邹乃祎, 单保恩, 马鸣, 祝淑钗. 干扰HMGB1基因表达对食管鳞癌细胞侵袭迁移及放射敏感性的影响[J]. 癌变·畸变·突变, 2021, 33(5): 327-333.
[2]	常晨, 杨荔艳, 蔡洪庆, 苑青, 郝佳洁, 王明荣. 食管鳞癌中SERPINE1 mRNA的表达及其临床意义[J]. 癌变·畸变·突变, 2021, 33(4): 245-249.
[3]	曾卓颖, 吴德生, 鲁晶晶, 廖慧, 赖洪飘, 袁建辉, 胡章立. 雌激素受体α介导氧化磷酸化通路在肺癌发生中的作用[J]. 癌变·畸变·突变, 2021, 33(4): 262-268.
[4]	赵丽, 王莉, 莫玲, 孙艳. 利拉鲁肽对脲链佐菌素诱导阿尔茨海默病大鼠认知功能及Tau蛋白磷酸化的影响[J]. 癌变·畸变·突变, 2021, 33(4): 280-285.
[5]	郑珺文, 常晨, 郝佳洁, 蔡岩, 王明荣, 张钰. NEDD4在食管鳞癌中的表达及作用研究[J]. 癌变·畸变·突变, 2021, 33(3): 203-207,224.
[6]	焦文静, 郭秀娟, 邵俊国, 焦文鹏, 张金艳. 中性粒细胞和血小板与淋巴细胞比值对食管鳞癌临床病理特征及预后的意义[J]. 癌变·畸变·突变, 2021, 33(3): 213-217.
[7]	范玉宏, 周海丰, 范爽, 王立坤, 侯雅雄, 刘博. CXCR-2在食管鳞癌组织中的表达及其与MMP-9、VEGF的相关性研究[J]. 癌变·畸变·突变, 2021, 33(3): 225-229,240.
[8]	张碟, 刘祥贺, 霍苗苗, 刘梅, 徐宁志, 朱红霞. MiR-195-5p对食管鳞癌细胞放射敏感性的影响及作用机制研究[J]. 癌变·畸变·突变, 2021, 33(2): 81-88,94.
[9]	古丽扎热叶·艾库拉, 谭遥, 帕力达·阿皮孜阿吉. 新疆哈萨克族食管鳞癌与长链非编码RNA表达的关系[J]. 癌变·畸变·突变, 2020, 32(3): 194-197,202.
[10]	师盼, 林重华, 舒易方, 瞿家权, 宋淑亮. 柠檬酸转运体SLC25A1对食管鳞癌细胞体外放射敏感性的影响及其分子机制[J]. 癌变·畸变·突变, 2020, 32(2): 132-138.
[11]	薄存香, 张玉, 白金, 韩茹, 陈尚雅, 赛林霖. 邻苯二甲酸二(2-乙基己)酯对小鼠睾丸损伤及p-CREB蛋白表达的影响[J]. 癌变·畸变·突变, 2019, 31(4): 319-322,330.
[12]	姜晓旭, 郑义鹏, 赵九洲, 李明哲, 朱敬朴, 王欣, 李永奇, 海春旭, 于卫华. M1型巨噬细胞糖代谢重编程机制及其在炎症启动中的关键作用[J]. 癌变·畸变·突变, 2019, 31(1): 79-81,85.
[13]	黎青叶, 柳晓玲, 吴小嫩, 郭萍, 陈雯, 陈丽萍. 组蛋白H3(Ser10)磷酸化在维持肿瘤细胞恶性表型中的作用[J]. 癌变·畸变·突变, 2018, 30(2): 81-86,91.
[14]	黄鹏程, 周长慧, 李申宁, 常艳. 基于流式细胞术的组蛋白γ-H2AX磷酸化检测方法的建立[J]. 癌变·畸变·突变, 2017, 29(4): 284-288.
[15]	解智慧, 杨海, 张钰, 郝佳洁, 蔡岩, 徐昕, 王明荣. 食管癌中KIAA1522基因的转录本及蛋白表达分析[J]. 癌变·畸变·突变, 2017, 29(3): 166-171.